Skip to main content
Biotricity, Inc. (BTCY)
NASDAQ: BTCY · IEX Real-Time Price · USD
0.824
-0.018 (-2.09%)
At close: Jul 19, 2024, 4:00 PM
0.890
+0.066 (7.99%)
Pre-market: Jul 22, 2024, 7:13 AM EDT

Biotricity Revenue

In the fiscal year ending March 31, 2024, Biotricity had annual revenue of $12.06M with 25.15% growth. Revenue in the quarter ending March 31, 2024 was $3.18M with 15.89% year-over-year growth.

Revenue (ttm)
$12.06M
Revenue Growth
+25.15%
P/S Ratio
1.47
Revenue / Employee
$219,334
Employees
55
Market Cap
17.70M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202412.06M2.42M25.15%
Mar 31, 20239.64M1.99M26.00%
Mar 31, 20227.65M4.27M126.02%
Mar 31, 20213.38M1.97M138.75%
Mar 31, 20201.42M1.02M256.03%
Mar 31, 2019398.20K--
Mar 31, 20180--
Mar 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
VBI Vaccines 9.41M
Aspira Women's Health 8.99M
Synlogic 3.21M
Aeterna Zentaris 2.37M
Lyra Therapeutics 1.68M
Aptorum Group 431.38K
GlycoMimetics 10.00K
Revenue Rankings

BTCY News

More News